Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators

BACKGROUND: Upregulation of endogenous angiostatin levels may constitute a novel anti-angiogenic, and therefore anti-tumor therapy. In vitro, angiostatin generation is a two-step process, starting with the conversion of plasminogen to plasmin by plasminogen activators (PAs). Next, plasmin excises an...

Descripción completa

Detalles Bibliográficos
Autores principales: de Groot-Besseling, Renate RJ, Ruers, Theo JM, Lamers-Elemans, Iris L, Maass, Cathy N, de Waal, Robert MW, Westphal, Johan R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560151/
https://www.ncbi.nlm.nih.gov/pubmed/16753063
http://dx.doi.org/10.1186/1471-2407-6-149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560151/
https://www.ncbi.nlm.nih.gov/pubmed/16753063
http://dx.doi.org/10.1186/1471-2407-6-149

Ejemplares similares